Heart failure study with cardiac resynchronization therapy
Part of Heart & circulation clinical trials.
This study looks at how a pacemaker-like device (cardiac resynchronization therapy) affects heart function in people with heart failure and reduced ejection fraction. It may help you understand if this treatment is right for you and could improve your heart health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have heart failure with reduced ejection fraction (a weak heart pump)
- Your doctor has confirmed that a cardiac resynchronization therapy (CRT) device is appropriate for you
- You are not pregnant
- You have no metal fragments in your body that would make an MRI unsafe
- You do not have advanced kidney disease (stage 4 or 5) and you are able to move around enough to do a 6-minute step test
- You have not had a heart attack or heart surgery within the last 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special noninvasive heart “mapping” test done on the body can help improve outcomes for people who need a CRT device. It studies whether mapping before implantation can better guide or predict how well the CRT will work.
This study tests a new heart scan method to help doctors place pacemakers more accurately for people with heart failure. It aims to improve the effectiveness of the pacemaker treatment and may lead to better outcomes for patients.
This study looks at whether implantable defibrillators can reduce dangerous heart rhythms in people with non-ischemic cardiomyopathy (heart weakness not caused by blocked heart arteries), a heart scar, and very low pumping strength despite best treatment. It compares different approaches to choosing which patients should receive these devices.
This trial compares three types of advanced pacemakers (cardiac resynchronization therapy devices) to see which works best for improving heart function and reducing abnormal heart rhythms in people with heart failure.
This trial evaluates a noninvasive way to assess who should get Cardiac Resynchronization Therapy (CRT), and to check results after implantation. If you fit the heart rhythm and heart pump criteria, the approach may help confirm whether CRT is appropriate for you.
This study uses advanced heart imaging to better understand heart function in people who may benefit from a cardiac resynchronization therapy (CRT) device. It aims to find ways to improve how doctors choose treatment and tailor care.
Hear when a new Heart Failure With Reduced Ejection Fraction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.